Research field (4):
Otorhinolaryngology
, Genetics
, Clinical pharmacy
, Cognitive neuroscience
Research keywords (2):
Hearing Loss, Clinical genetics, Hearing-related dementia
, Drug induced sleepiness and performance, Expression of effects of allergy treatment drugs
Research theme for competitive and other funds (3):
2021 - 2024 難治性好酸球炎症における新しいプログラム細胞死を標的とした治療法の開発
2017 - 2019 携帯型聴覚検査機器を用いた高齢者聴覚スクリーニング検査の開発
2018 - 2018 Research on changes in bacterial flora in the human body due to external factors
Papers (53):
Yutaka Tateda, Takahiro Suzuki, Teruyuki Sato, Kenji Izuhara, Kazue Ise, Hiroki Shimada, Keigo Murakami, Kazuhiro Murakami, Yasuhiro Nakamura, Nobuo Ohta. Expression of Periostin in Benign Salivary Gland Tumors. The Tohoku journal of experimental medicine. 2023. 63
Teruyuki Sato, Youji Tareishi, Takahiro Suzuki, Nanako Ansai, Chikara Asaka, Nobuo Ohta. Effect of second-generation antihistamines on nighttime sleep and daytime sleepiness in patients with allergic rhinitis. Sleep & breathing = Schlaf & Atmung. 2023. 27. 6. 2389-2395
2023/04 - Japanese Society of Allergology Sanofi Excellent Paper Award Periostin is an aggravating factor and predictive biomarker of eosinophilic chronic rhinosinusitis